Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
World Journal of Gastroenterology|July 31, 2004
Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cellsYi-Ying Wu, Hwei-Fang Tsai, We-Cheng Lin, et al.
Digestive Diseases and Sciences|December 22, 2017
Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life ExperienceBei Tan, Jyh-Chin Yang, Carol L Young, et al.
Helicobacter|March 1, 2017
Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey)Yoen-Young Chuah, Deng-Chyang Wu, Seng-Kee Chuah, et al.
Proteomics|May 21, 2011
Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarkerChien-Wei Tseng, Jyh-Chin Yang, Chiung-Nien Chen, et al.
BMJ Open Gastroenterology|September 5, 2020
Efficacy of second-line regimens for <i>Helicobacter pylori</i> eradication treatment: a systemic review and network meta-analysisYen-Lin Chang, Yu-Chun Tung, Yu-Kang Tu, et al.
Scientific Reports|November 8, 2016
Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancerYu-Lin Su, Hsiang-Ling Huang, Bo-Shih Huang, et al.
Helicobacter|September 26, 2022
REAP-HP survey 2020: Comparing the real-world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020Yoen-Young Chuah, Deng-Chyang Wu, Seng-Kee Chuah, et al.
Microorganisms|January 26, 2024
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of <i>Helicobacter pylori</i> InfectionChien-Lin Chen, I-Ting Wu, Deng-Chyang Wu, et al.
The American Journal of Gastroenterology|June 25, 2025
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized TrialPing-I Hsu, Chien-Lin Chen, Chih-An Shih, et al.
The American Journal of Gastroenterology|March 20, 2023
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized TrialPing-I Hsu, Kuan-Yang Chen, Wei-Chen Tai, et al.
Pageof 5